Cargando…

Multicenter Evaluation of the BD Phoenix CPO Detect Test for Detection and Classification of Carbapenemase-Producing Organisms in Clinical Isolates

Limited treatment options contribute to high morbidity/mortality rates with carbapenem-resistant, Gram-negative bacterial infections. New approaches for carbapenemase-producing organism (CPO) detection may help inform clinician decision-making on patient treatment and infection control. BD Phoenix C...

Descripción completa

Detalles Bibliográficos
Autores principales: Whitley, Vicki, Kircher, Susan, Gill, Tracey, Hindler, Janet A., O’Rourke, Susan, Cooper, Charles, Tulpule, Anagha, Denys, Gerald A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7180248/
https://www.ncbi.nlm.nih.gov/pubmed/32132195
http://dx.doi.org/10.1128/JCM.01752-19
_version_ 1783525782906208256
author Whitley, Vicki
Kircher, Susan
Gill, Tracey
Hindler, Janet A.
O’Rourke, Susan
Cooper, Charles
Tulpule, Anagha
Denys, Gerald A.
author_facet Whitley, Vicki
Kircher, Susan
Gill, Tracey
Hindler, Janet A.
O’Rourke, Susan
Cooper, Charles
Tulpule, Anagha
Denys, Gerald A.
author_sort Whitley, Vicki
collection PubMed
description Limited treatment options contribute to high morbidity/mortality rates with carbapenem-resistant, Gram-negative bacterial infections. New approaches for carbapenemase-producing organism (CPO) detection may help inform clinician decision-making on patient treatment and infection control. BD Phoenix CPO detect (CPO detect) detects and classifies carbapenemases in Enterobacterales, Acinetobacter baumannii, and Pseudomonas aeruginosa during susceptibility testing. The clinical performance of CPO detect is reported here. Enterobacterales, Acinetobacter baumannii, and Pseudomonas aeruginosa isolates were evaluated across three sites using CPO detect and a composite reference method (RM); the latter was comprised of the modified carbapenem inactivation method and a MIC screen for ertapenem, imipenem, and meropenem. Multiplex PCR testing was also utilized for Ambler class determination. Positive and negative percentages of agreement (PPA and NPA, respectively) between CPO detect and the RM were determined. The PPA and NPA for Enterobacterales were 98.5% (confidence intervals, 96.6%, 99.4%) and 97.2% (95.8%, 98.2%), respectively. The A. baumannii PPA and NPA, respectively, were 97.1% (90.2%, 99.2%) and 97.1% (89.9%, 99.2%). The P. aeruginosa PPA and NPA, respectively, were 95.9% (88.6%, 98.6%) and 92.3% (86.7%, 95.6%). The PPA values for carbapenemase class designations for all organisms combined and Enterobacterales alone, respectively, were 95.3% (90.2%, 97.8%) and 94.6% (88.8%, 97.5%) for class A, 94.0% (88.7%, 96.6%) and 96.4% (90.0%, 98.8%) for class B, and 95.0% (90.1%, 97.6%) and 99.0% (94.4%, 99.8%) for class D carbapenemases. NPA values for all organisms and Enterobacterales alone ranged from 98.5% to 100%. CPO detect provided accurate detection and classification of CPOs for the majority of isolates of Enterobacterales, Acinetobacter baumannii, and Pseudomonas aeruginosa tested.
format Online
Article
Text
id pubmed-7180248
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher American Society for Microbiology
record_format MEDLINE/PubMed
spelling pubmed-71802482020-04-27 Multicenter Evaluation of the BD Phoenix CPO Detect Test for Detection and Classification of Carbapenemase-Producing Organisms in Clinical Isolates Whitley, Vicki Kircher, Susan Gill, Tracey Hindler, Janet A. O’Rourke, Susan Cooper, Charles Tulpule, Anagha Denys, Gerald A. J Clin Microbiol Bacteriology Limited treatment options contribute to high morbidity/mortality rates with carbapenem-resistant, Gram-negative bacterial infections. New approaches for carbapenemase-producing organism (CPO) detection may help inform clinician decision-making on patient treatment and infection control. BD Phoenix CPO detect (CPO detect) detects and classifies carbapenemases in Enterobacterales, Acinetobacter baumannii, and Pseudomonas aeruginosa during susceptibility testing. The clinical performance of CPO detect is reported here. Enterobacterales, Acinetobacter baumannii, and Pseudomonas aeruginosa isolates were evaluated across three sites using CPO detect and a composite reference method (RM); the latter was comprised of the modified carbapenem inactivation method and a MIC screen for ertapenem, imipenem, and meropenem. Multiplex PCR testing was also utilized for Ambler class determination. Positive and negative percentages of agreement (PPA and NPA, respectively) between CPO detect and the RM were determined. The PPA and NPA for Enterobacterales were 98.5% (confidence intervals, 96.6%, 99.4%) and 97.2% (95.8%, 98.2%), respectively. The A. baumannii PPA and NPA, respectively, were 97.1% (90.2%, 99.2%) and 97.1% (89.9%, 99.2%). The P. aeruginosa PPA and NPA, respectively, were 95.9% (88.6%, 98.6%) and 92.3% (86.7%, 95.6%). The PPA values for carbapenemase class designations for all organisms combined and Enterobacterales alone, respectively, were 95.3% (90.2%, 97.8%) and 94.6% (88.8%, 97.5%) for class A, 94.0% (88.7%, 96.6%) and 96.4% (90.0%, 98.8%) for class B, and 95.0% (90.1%, 97.6%) and 99.0% (94.4%, 99.8%) for class D carbapenemases. NPA values for all organisms and Enterobacterales alone ranged from 98.5% to 100%. CPO detect provided accurate detection and classification of CPOs for the majority of isolates of Enterobacterales, Acinetobacter baumannii, and Pseudomonas aeruginosa tested. American Society for Microbiology 2020-04-23 /pmc/articles/PMC7180248/ /pubmed/32132195 http://dx.doi.org/10.1128/JCM.01752-19 Text en Copyright © 2020 Whitley et al. https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Bacteriology
Whitley, Vicki
Kircher, Susan
Gill, Tracey
Hindler, Janet A.
O’Rourke, Susan
Cooper, Charles
Tulpule, Anagha
Denys, Gerald A.
Multicenter Evaluation of the BD Phoenix CPO Detect Test for Detection and Classification of Carbapenemase-Producing Organisms in Clinical Isolates
title Multicenter Evaluation of the BD Phoenix CPO Detect Test for Detection and Classification of Carbapenemase-Producing Organisms in Clinical Isolates
title_full Multicenter Evaluation of the BD Phoenix CPO Detect Test for Detection and Classification of Carbapenemase-Producing Organisms in Clinical Isolates
title_fullStr Multicenter Evaluation of the BD Phoenix CPO Detect Test for Detection and Classification of Carbapenemase-Producing Organisms in Clinical Isolates
title_full_unstemmed Multicenter Evaluation of the BD Phoenix CPO Detect Test for Detection and Classification of Carbapenemase-Producing Organisms in Clinical Isolates
title_short Multicenter Evaluation of the BD Phoenix CPO Detect Test for Detection and Classification of Carbapenemase-Producing Organisms in Clinical Isolates
title_sort multicenter evaluation of the bd phoenix cpo detect test for detection and classification of carbapenemase-producing organisms in clinical isolates
topic Bacteriology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7180248/
https://www.ncbi.nlm.nih.gov/pubmed/32132195
http://dx.doi.org/10.1128/JCM.01752-19
work_keys_str_mv AT whitleyvicki multicenterevaluationofthebdphoenixcpodetecttestfordetectionandclassificationofcarbapenemaseproducingorganismsinclinicalisolates
AT kirchersusan multicenterevaluationofthebdphoenixcpodetecttestfordetectionandclassificationofcarbapenemaseproducingorganismsinclinicalisolates
AT gilltracey multicenterevaluationofthebdphoenixcpodetecttestfordetectionandclassificationofcarbapenemaseproducingorganismsinclinicalisolates
AT hindlerjaneta multicenterevaluationofthebdphoenixcpodetecttestfordetectionandclassificationofcarbapenemaseproducingorganismsinclinicalisolates
AT orourkesusan multicenterevaluationofthebdphoenixcpodetecttestfordetectionandclassificationofcarbapenemaseproducingorganismsinclinicalisolates
AT coopercharles multicenterevaluationofthebdphoenixcpodetecttestfordetectionandclassificationofcarbapenemaseproducingorganismsinclinicalisolates
AT tulpuleanagha multicenterevaluationofthebdphoenixcpodetecttestfordetectionandclassificationofcarbapenemaseproducingorganismsinclinicalisolates
AT denysgeralda multicenterevaluationofthebdphoenixcpodetecttestfordetectionandclassificationofcarbapenemaseproducingorganismsinclinicalisolates